
- Cardiovascular
- Trials in setup
IVORY
Low-dose interleukin-2 for the reduction of vascular inflammation in Acute Coronary Syndromes
Research summary
Information coming soon
Low-dose interleukin-2 for the reduction of vascular inflammation in Acute Coronary Syndromes
Information coming soon